GET DAILY SIGNALSHippo Holdings (HIPO) Delivers Strong Q3 2026 Results with Revenue Up +29.4%
Key Takeaways
- Hippo Holdings reported third-quarter 2026 revenue of $156 million, up 29.4% year over year and ahead of the roughly $153.9 million consensus estimate.
- Adjusted earnings per share (EPS) reached $0.74, up from $0.70 a year ago and comfortably above the $0.48 Wall Street consensus.
- Gross written premium (GWP) — the total premium written before reinsurance — climbed 60.1% to $498.1 million.
- The combined ratio improved to 98.4%, marking a fifth consecutive quarter of underwriting profitability (a ratio below 100% signals an underwriting profit).
- Hippo raised its full-year 2026 guidance for revenue, GWP, and adjusted net income while lowering its combined-ratio outlook.
- GAAP net income was $9 million, or $0.33 per diluted share, down from $98 million a year earlier, which included a one-time gain.
Why This Earnings Update Matters
HIPO is a technology-native insurance platform that has spent several years repositioning its business away from a heavy reliance on homeowners insurance toward more diversified commercial and casualty lines. That shift is central to the third-quarter report, because it is intended to reduce earnings volatility and drive more predictable underwriting results. For investors, this earnings update serves as a test of whether the company can sustain both premium growth and profitability at scale. After reaching its first annual adjusted profit in 2025, HIPO entered 2026 with momentum, and its quarterly results have become a closely watched gauge of execution across growth, underwriting discipline, and expense management. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Results
HIPO reported total revenue of $156 million for the third quarter of 2026, a 29.4% increase from $120.6 million in the prior-year period and slightly above the consensus estimate of roughly $153.9 million. Adjusted net income was $20 million, or $0.74 per diluted share, up 9.3% from $18 million a year earlier and well above the $0.48 consensus, representing an earnings surprise of more than 50%. On a GAAP basis, net income was $9 million, or $0.33 per diluted share, compared with $98 million in the year-ago quarter, which included a significant one-time gain.
Operating momentum was broad-based. Gross written premium (GWP) rose 60.1% to $498.1 million, while net written premium (NWP) — premium retained after reinsurance — increased 26% to $149.1 million. Net earned premium grew 29% to $128.3 million. The combined ratio — a key insurance measure adding losses and expenses as a percentage of premium, where lower is better — improved to 98.4% from 99.6%, driven in part by an expense ratio that fell to 41.7% from 52.0% a year earlier. From what I see, this efficiency improvement stands out as a key driver.
Management also raised its full-year 2026 outlook, lifting revenue guidance to a range of $585 million to $590 million, GWP guidance to $1.70 billion to $1.75 billion, and adjusted net income guidance to $77 million to $80 million, while lowering its expected combined ratio to 97% to 98%. Book value per share reached $17.62, up from $16.97 at the end of 2025.
Market Reaction and Investor Sentiment
HIPO shares moved higher in premarket trading after the results, as investors responded positively to the combination of a top-line beat, an adjusted EPS surprise, and raised guidance. The stock had already gained roughly 25% year to date, outperforming the broader market, reflecting growing confidence in the company's diversification strategy and improving profitability. Sentiment around the quarter was generally constructive, with the fifth straight period of underwriting profitability reinforcing the view that HIPO's operating model is scaling efficiently. Still, the sharp year-over-year decline in GAAP net income — a function of the prior-year one-time gain — is a reminder that headline comparisons can obscure underlying progress, and investors are likely to continue focusing on adjusted results and premium trends rather than raw net income figures. I’m watching this closely as the adjusted metrics paint a clearer picture of ongoing execution.
Forward Outlook and Key Factors to Monitor
Looking ahead, the most important signal from this report is the upgraded guidance, which points to continued growth and margin expansion through the rest of 2026. Investors will want to monitor whether HIPO can sustain its premium momentum without sacrificing underwriting discipline, particularly as it scales its commercial multi-peril and casualty lines, both of which delivered strong year-over-year growth.
Expense leverage remains a key watch item. The company has attributed much of its efficiency gains to AI-powered customer support and operational automation, and the ability to keep expenses growing more slowly than revenue will be central to further combined-ratio improvement. Catastrophe losses are another factor, given that HIPO lowered its catastrophe-loss ratio assumption for the year, and any unexpected weather events could pressure results.
Finally, retention trends and the mix of business will matter. Management has signaled that net written premium retention may normalize at lower levels as the company deliberately shifts toward diversified, program-based distribution. Balancing top-line growth, retention, and profitability will be the central story investors follow in the quarters ahead as HIPO works toward its longer-term premium and profitability targets.
Integrating Tickeron’s AI Screener into My Research
In my own analysis of earnings reports like this one, I often turn to Tickeron’s AI Screener to quickly filter for comparable names in the insurance sector and spot any emerging technical patterns. It helps me cross-check fundamentals against peers without spending hours on manual scans, and the customizable filters for volatility and performance metrics add useful context around names showing similar momentum. This approach keeps my process efficient while highlighting potential watchlist additions aligned with the trends I’m already following in HIPO.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HIPO in -2.98% downward trend, sliding for three consecutive days on October 29, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HIPO declined for three days, in 265 of 314 cases, the price declined further within the following month. The odds of a continued downward trend are 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for HIPO moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 19 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 53 cases where HIPO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.
HIPO broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on HIPO as a result. In 79 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for HIPO just turned positive on October 02, 2026. Looking at past instances where HIPO's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.
HIPO moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HIPO crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +3.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIPO advanced for three days, in 188 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 118 of 155 cases where HIPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. HIPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.106) is normal, around the industry mean (-2.361). P/E Ratio (7.790) is within average values for comparable stocks, (8.990). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.303). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (1.675) is also within normal values, averaging (1.594).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PropertyCasualtyInsurance